| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study
|
Ryan, Charles J
|
|
2015
|
16 |
2 |
p. 152-160
9 p.
|
artikel
|
| 2 |
Abiraterone's efficacy confirmed; time to aim higher
|
Madan, Ravi
|
|
2015
|
16 |
2 |
p. 119-121
3 p.
|
artikel
|
| 3 |
Adjuvant chemotherapy after preoperative (chemo)radiotherapy and surgery for patients with rectal cancer: a systematic review and meta-analysis of individual patient data
|
Breugom, Anne J
|
|
2015
|
16 |
2 |
p. 200-207
8 p.
|
artikel
|
| 4 |
Adjuvant treatment for HER2-positive breast cancer
|
Burki, Talha Khan
|
|
2015
|
16 |
2 |
p. e59-
1 p.
|
artikel
|
| 5 |
Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials
|
Yang, James Chih-Hsin
|
|
2015
|
16 |
2 |
p. 141-151
11 p.
|
artikel
|
| 6 |
Black cohosh, hot flushes, and breast cancer
|
Merchant, Shairoz
|
|
2015
|
16 |
2 |
p. 137-138
2 p.
|
artikel
|
| 7 |
Building a global consensus approach to chordoma: a position paper from the medical and patient community
|
Stacchiotti, Silvia
|
|
2015
|
16 |
2 |
p. e71-e83
nvt p.
|
artikel
|
| 8 |
Carbon ion radiotherapy in Japan: an assessment of 20 years of clinical experience
|
Kamada, Tadashi
|
|
2015
|
16 |
2 |
p. e93-e100
nvt p.
|
artikel
|
| 9 |
Chemoradiotherapy with or without panitumumab in patients with unresected, locally advanced squamous-cell carcinoma of the head and neck (CONCERT-1): a randomised, controlled, open-label phase 2 trial
|
Mesía, Ricard
|
|
2015
|
16 |
2 |
p. 208-220
13 p.
|
artikel
|
| 10 |
Combined treatment for only half of Hodgkin's patients
|
Mayor, Susan
|
|
2015
|
16 |
2 |
p. e59-
1 p.
|
artikel
|
| 11 |
Commercial solariums banned in Australia
|
Howe, Megan
|
|
2015
|
16 |
2 |
p. e58-
1 p.
|
artikel
|
| 12 |
Correction to Lancet Oncol 2015; 16: 87
|
|
|
2015
|
16 |
2 |
p. e55-
1 p.
|
artikel
|
| 13 |
Courage Unmasked
|
Cather, Hannah
|
|
2015
|
16 |
2 |
p. 139-140
2 p.
|
artikel
|
| 14 |
Disease-free survival after complete mesocolic excision compared with conventional colon cancer surgery: a retrospective, population-based study
|
Bertelsen, Claus Anders
|
|
2015
|
16 |
2 |
p. 161-168
8 p.
|
artikel
|
| 15 |
Dose escalation in lung cancer: have we gone full circle?
|
Faivre-Finn, Corinne
|
|
2015
|
16 |
2 |
p. 125-127
3 p.
|
artikel
|
| 16 |
Dual HER2 inhibition and paclitaxel in metastatic breast cancer
|
Brower, Vicki
|
|
2015
|
16 |
2 |
p. e57-
1 p.
|
artikel
|
| 17 |
EGFR-based bioradiotherapy in SCCHN
|
Saloura, Vassiliki
|
|
2015
|
16 |
2 |
p. 129-130
2 p.
|
artikel
|
| 18 |
Familial gastric cancer: genetic susceptibility, pathology, and implications for management
|
Oliveira, Carla
|
|
2015
|
16 |
2 |
p. e60-e70
nvt p.
|
artikel
|
| 19 |
FDA approves new upgraded Gardasil 9
|
Kirby, Tony
|
|
2015
|
16 |
2 |
p. e56-
1 p.
|
artikel
|
| 20 |
HPV vaccination not linked to multiple sclerosis
|
Tanday, Sanjay
|
|
2015
|
16 |
2 |
p. e57-
1 p.
|
artikel
|
| 21 |
Ibrutinib for previously untreated and relapsed or refractory chronic lymphocytic leukaemia with TP53 aberrations: a phase 2, single-arm trial
|
Farooqui, Mohammed Z H
|
|
2015
|
16 |
2 |
p. 169-176
8 p.
|
artikel
|
| 22 |
Immunotherapy improves overall survival in pancreatic cancer
|
Mayor, Susan
|
|
2015
|
16 |
2 |
p. e58-
1 p.
|
artikel
|
| 23 |
LUX-Lung: determining the best EGFR inhibitor in NSCLC?
|
Rossi, Antonio
|
|
2015
|
16 |
2 |
p. 118-119
2 p.
|
artikel
|
| 24 |
Ovarian suppression and breast cancer
|
Burki, Talha Khan
|
|
2015
|
16 |
2 |
p. e56-
1 p.
|
artikel
|
| 25 |
Panitumumab plus radiotherapy versus chemoradiotherapy in patients with unresected, locally advanced squamous-cell carcinoma of the head and neck (CONCERT-2): a randomised, controlled, open-label phase 2 trial
|
Giralt, Jordi
|
|
2015
|
16 |
2 |
p. 221-232
12 p.
|
artikel
|
| 26 |
Prostate cancer: a practical guide
|
van Dorn, Aaron
|
|
2015
|
16 |
2 |
p. 138-139
2 p.
|
artikel
|
| 27 |
Putting palliative care on the global health agenda
|
Powell, Richard A
|
|
2015
|
16 |
2 |
p. 131-133
3 p.
|
artikel
|
| 28 |
Quality of surgery: has the time come for colon cancer?
|
Quirke, Phil
|
|
2015
|
16 |
2 |
p. 121-122
2 p.
|
artikel
|
| 29 |
Radiotherapy or surgery for the axilla in node-positive breast cancer?
|
Farace, Paolo
|
|
2015
|
16 |
2 |
p. e53-e54
nvt p.
|
artikel
|
| 30 |
Radiotherapy or surgery for the axilla in node-positive breast cancer?
|
Livi, Lorenzo
|
|
2015
|
16 |
2 |
p. e53-
1 p.
|
artikel
|
| 31 |
Radiotherapy or surgery for the axilla in node-positive breast cancer? – Authors' reply
|
Donker, Mila
|
|
2015
|
16 |
2 |
p. e54-
1 p.
|
artikel
|
| 32 |
Recalibrating emergency care in the UK
|
The Lancet Oncology,
|
|
2015
|
16 |
2 |
p. 117-
1 p.
|
artikel
|
| 33 |
Regenerative medicine for oesophageal reconstruction after cancer treatment
|
Chian, Kerm Sin
|
|
2015
|
16 |
2 |
p. e84-e92
nvt p.
|
artikel
|
| 34 |
2014 San Antonio Breast Cancer Symposium
|
Yaqub, Farhat
|
|
2015
|
16 |
2 |
p. 135-136
2 p.
|
artikel
|
| 35 |
Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study
|
Bradley, Jeffrey D
|
|
2015
|
16 |
2 |
p. 187-199
13 p.
|
artikel
|
| 36 |
Sunitinib in patients with chemotherapy-refractory thymoma and thymic carcinoma: an open-label phase 2 trial
|
Thomas, Anish
|
|
2015
|
16 |
2 |
p. 177-186
10 p.
|
artikel
|
| 37 |
Sunitinib in thymic carcinoma: enigmas still unresolved
|
Marx, Alexander
|
|
2015
|
16 |
2 |
p. 124-125
2 p.
|
artikel
|
| 38 |
The paradox of preoperative (chemo)radiotherapy for rectal cancer
|
Valentini, Vincenzo
|
|
2015
|
16 |
2 |
p. 127-128
2 p.
|
artikel
|
| 39 |
Towards a global cancer fund
|
Cavalli, Franco
|
|
2015
|
16 |
2 |
p. 133-134
2 p.
|
artikel
|
| 40 |
Understanding cancer cell survival is key to patient survival
|
Fegan, Chris
|
|
2015
|
16 |
2 |
p. 122-124
3 p.
|
artikel
|
Tijdschrift beschrijving